The previous studies verified that the HTGW phenotype could be used as an inexpensive screening tool to identify individuals characterized by the atherogenic metabolic triad (hyperinsulinemia, elevated apolipoprotein B, and small dense LDL-C particles) (7, 27). This evidence concerns the gene APOB and Hyperinsulinemia.